Viewing Study NCT00866320


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:20 AM
Study NCT ID: NCT00866320
Status: COMPLETED
Last Update Posted: 2014-07-23
First Post: 2009-03-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab
Sponsor: Case Comprehensive Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-02
Start Date Type: None
Primary Completion Date: 2009-12
Primary Completion Date Type: ACTUAL
Completion Date: 2009-12
Completion Date Type: ACTUAL
First Submit Date: 2009-03-19
First Submit QC Date: None
Study First Post Date: 2009-03-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-12-27
Results First Submit QC Date: None
Results First Post Date: 2012-02-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-14
Last Update Post Date: 2014-07-23
Last Update Post Date Type: ESTIMATED